Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors

Although imatinib mesylate (IM) has revolutionized the management of gastrointestinal stromal tumors (GISTs), drug resistance remains a challenge. Previous studies have shown that the expression of aurora kinase A (AURKA) predicts recurrence in patients with primary, surgically resected GISTs. The c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Chun-Nan, Yen, Chueh-Chuan, Chen, Yen-Yang, Cheng, Chi-Tung, Huang, Shih-Chiang, Chang, Ting-Wei, Yao, Fang-Yi, Lin, Yung-Chan, Wen, Yao-Shan, Chiang, Kun-Chun, Chen, Jen-Shi, Yeh, Ta-Sen, Tzeng, Cheng-Hwai, Chao, Ta-Chung, Fletcher, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147307/
https://www.ncbi.nlm.nih.gov/pubmed/24901229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147307/
https://www.ncbi.nlm.nih.gov/pubmed/24901229

Ejemplares similares